Factors impacting early mortality in tuberculosis/HIV patients: differences between subjects naïve to and previously started on HAART.
BACKGROUND: Mortality among patients with tuberculosis (TB)/HIV is highest during the first few months of antituberculous therapy. The objective of this study was to assess the factors associated with early mortality among TB/HIV patients and whether these factors are similar for HAART naïve and tho...
Main Authors: | Carolina Arana Stanis Schmaltz, Guilherme Santoro-Lopes, Maria Cristina Lourenço, Mariza Gonçalves Morgado, Luciane de Souza Velasque, Valéria Cavalcanti Rolla |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3458068?pdf=render |
Similar Items
-
Effectiveness of highly active antiretroviral therapy (HAART) used concomitantly with rifampicin in patients with tuberculosis and AIDS
by: Flávia Marinho Sant'Anna, et al. -
Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?
by: Carolina Arana Stanis Schmaltz, et al.
Published: (2019-02-01) -
Risk factors for increased immune reconstitution in response to Mycobacterium tuberculosis antigens in tuberculosis HIV-infected, antiretroviral-naïve patients
by: Tatiana Pereira da Silva, et al.
Published: (2017-09-01) -
Survival of HIV patients with tuberculosis started on simultaneous or deferred HAART in the THRio cohort, Rio de Janeiro, Brazil
by: Valeria Saraceni, et al.
Published: (2014-09-01) -
Cutaneous tuberculosis and HIV infection at a referral centre in Rio de Janeiro, Brazil
by: Danielle Mann, et al.
Published: (2018-07-01)